These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS? Lambrechts D; Storkebaum E; Carmeliet P Trends Mol Med; 2004 Jun; 10(6):275-82. PubMed ID: 15177192 [TBL] [Abstract][Full Text] [Related]
17. AMPA receptor-mediated neuronal death in sporadic ALS. Kwak S; Hideyama T; Yamashita T; Aizawa H Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521 [TBL] [Abstract][Full Text] [Related]
18. CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. Tovar-Y-Romo LB; Zepeda A; Tapia R J Neuropathol Exp Neurol; 2007 Oct; 66(10):913-22. PubMed ID: 17917585 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord. Ramamohan PY; Gourie-Devi M; Nalini A; Shobha K; Ramamohan Y; Joshi P; Raju TR Amyotroph Lateral Scler; 2007 Apr; 8(2):79-82. PubMed ID: 17453633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]